SCHEMBL20334065

SCHEMBL20334065

C/C=C1\CNC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15624030 0.68 ALDH1A1 (0.40)
SCHEMBL14613693 0.68
SCHEMBL27405833 0.68
SCHEMBL19752668 0.65 MB (0.33)
Hydantoin SCHEMBL9798274 0.65
Hydantoin SCHEMBL27690 0.64
Hydantoin SCHEMBL7285865 0.64
Hydantoin SCHEMBL27705088 0.64 CRBN (0.52)
SCHEMBL22912366 0.63
SCHEMBL988003 0.63 ALDH1A1 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10906887-B2 Amino compounds for treatment of immune and inflammatory disorders ACHILLION PHARMACEUTICALS, INC. (US) 2021-02-02 US disclosed
US-20180179185-A1 AMINO COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2018-06-28 US disclosed